RETRACTED: 4,5-Dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity.
about
Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with Src and P85 alphaEpidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase.Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and diseaseRETRACTED: Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats.Tyrosine kinases in disease: overview of kinase inhibitors as therapeutic agents and current drugs in clinical trials.The transcription factor AP-1 is required for EGF-induced activation of rho-like GTPases, cytoskeletal rearrangements, motility, and in vitro invasion of A431 cells.Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2.Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling.Signal transduction interception as a novel approach to disease management.Antagonistic and agonistic effects of quinazoline tyrosine kinase inhibitors on mutant EGF receptor function.Regulation of heparin-binding EGF-like growth factor expression in Ha-ras transformed human mammary epithelial cells.α1-Adrenoceptor-mediated contraction of rat aorta is partly mediated via transactivation of the epidermal growth factor receptorGefitinib induces myeloid differentiation of acute myeloid leukemia.Transforming growth factor-alpha acting at the epidermal growth factor receptor reduces infarct volume after permanent middle cerebral artery occlusion in rats.
P2860
Q24328857-8B441C63-A39B-4494-AF3E-C1C3A02EBB04Q24522441-F50FCF77-8541-49EC-BE7B-ABEE86217E88Q24538180-7DEEDAF7-36E4-41AF-BF42-CBD3AE3EC1C7Q24677033-62B9011F-C5B4-4CA9-A51F-32EBCACE485BQ34308033-8348C463-255C-4960-9884-15725D7894B2Q35787237-22B1497E-F54F-4228-A009-15084BCB581DQ36181201-8A843D09-AFED-46C0-867F-06BF602273E3Q36255893-1F30B814-94FF-497B-9C2F-AF2E7E53099AQ36556065-D2111916-3D8B-4F60-8C6C-9F583F6B55D4Q40015717-9EE95D3A-771E-4A7D-93DB-A3648C408AFDQ40374623-98E687A2-587A-4117-AFFB-54A59C56D7DAQ40706812-8843487A-CFE0-49E7-AFBF-7BF434C33D48Q40828652-67A97431-4516-4603-8A65-66EE5ECC026EQ41121778-0F5DDFE4-34CA-4737-A909-1FDF73FA41ADQ42742416-4E64DA21-6B51-4F79-BAB0-70565C9003C9Q48278467-5090F809-0FDD-4D66-B671-C9D51BF167DF
P2860
RETRACTED: 4,5-Dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity.
description
1994 nî lūn-bûn
@nan
1994 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մարտին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
name
RETRACTED: 4,5-Dianilinophthal ...... nt in vivo antitumor activity.
@ast
RETRACTED: 4,5-Dianilinophthal ...... nt in vivo antitumor activity.
@en
type
label
RETRACTED: 4,5-Dianilinophthal ...... nt in vivo antitumor activity.
@ast
RETRACTED: 4,5-Dianilinophthal ...... nt in vivo antitumor activity.
@en
altLabel
4,5-Dianilinophthalimide: a pr ...... nt in vivo antitumor activity.
@en
prefLabel
RETRACTED: 4,5-Dianilinophthal ...... nt in vivo antitumor activity.
@ast
RETRACTED: 4,5-Dianilinophthal ...... nt in vivo antitumor activity.
@en
P2093
P2860
P356
P1476
RETRACTED: 4,5-Dianilinophthal ...... nt in vivo antitumor activity.
@en
P2093
Buchdunger E
Regenass U
P2860
P304
P356
10.1073/PNAS.91.6.2334
P407
P577
1994-03-01T00:00:00Z